Cargando…
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon
Some therapies for diabetes increase the risk of hypoglycaemia, in particular all insulins and insulin secretagogues, including the glinides and sulfonylureas. Hypoglycaemia remains a major limiting factor to successful glycaemic management, despite the availability of prevention options such as ins...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079012/ https://www.ncbi.nlm.nih.gov/pubmed/31820562 http://dx.doi.org/10.1111/dom.13941 |